Navigation Links
Watson to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
Date:6/1/2011

PARSIPPANY, N.J., June 1, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the 2011 Goldman Sachs 32nd Annual Global Healthcare Conference on Wednesday, June 8, 2011 at 11:00am Eastern Time at the Terranea Resort in Rancho Palos Verdes, California. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com.  The webcast can also be accessed at the following URL:

http://cc.talkpoint.com/gold006/060711a_lr/?entity=4_BHJFWWH

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)CONTACTS:Investors:Patty Eisenhaur(862) 261-8141Media:Charlie Mayr(862) 261-8030
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)...  Decision Resources, one of the world,s leading ... issues, finds that, for the treatment of rheumatoid ... rheumatologists cite a therapy,s induction of remission as ... prescribing decisions. Over 60 percent and 70 percent ... percentage of patients achieving remission at six months ...
(Date:6/19/2013)... JOSE, Calif. , June 19, 2013 BD ... BDX ), a leading global medical technology company, ... Cell Analyzer , the latest in its line of high-performance ... Cell Analyzer delivers high-performance multicolor analysis with the most compact ... X 73.7 cm) and a height of 30" (76.2 cm). ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- In ... new specialty pharmaceutical company dedicated to advancing ... injectable and sustained release drug therapies in ... needs, today announced the acquisition of Enzon ... platform and associated product pipeline. Acquisition of ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
(Date:6/19/2013)... (PRWEB) June 19, 2013 DiscountFurnaceFilter.com, the number ... to offer the 5-2-1 Compressor Saver kit at an exceptional ... Start Kit) aids the air conditioning unit during start up, ... prevent air compressor or unit burn out. , The ... so the air conditioner uses less power to start and ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Alternatives, a ... some patients to quit using drugs while allowing them ... Jaffe, the founders of Alternatives, believe that abstinence-only approaches ... they enter treatment and that this approach hurts instead ... people in the United States need treatment for addiction ...
(Date:6/19/2013)... 19, 2013 Kansas City will host its first ... Street Day . A section of Main Street in the midtown ... afternoon of the event. The Main Street Corridor Development ... will help Kansas City join the ranks of dozens of cities ... tool to foster community vibrancy and active lifestyles. , “Ciclovia is ...
(Date:6/19/2013)... 19, 2013 Many trying-to-conceive couples ... medically necessary, according to a recent study ... Journal. The results of this research confirm what ... a decade – that trying-to-conceive women would benefit ... healthy body weight. Fairhaven Health is a leading ...
(Date:6/19/2013)... In 2011, the value of the Serbian ... drugs form the largest sector, accounting for nearly one ... is a significant contributor to the local economy; it ... 50% of the total domestic chemical industry output fall ... and Zdravlje Actavis are key participants in the Serbian ...
Breaking Medicine News(10 mins):Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2
... Danaher Corporation (NYSE: DHR ) announced that President ... presenting at the Morgan Stanley Global Industrials Conference in New ... EDT. The audio will be simultaneously webcast on www.danaher.com. A ... following the presentation. , , Danaher Corporation ...
... , THE WOODLANDS, Texas, Aug. 26 ... providing a service called Custom Separation Synthesis(TM) to customers primarily ... separation problems for which they would like more economically viable ... alternative separation schemes that are lower in capital and operating ...
... Pa., Aug. 26 Environmental Tectonics Corporation,s (OTC Bulletin ... a product division in ETC,s Controls Systems Group, has ... installation of the first BARA-MED((R)) computerized monoplace hyperbaric chamber ... International is a "turn-key" supplier, providing all the necessary ...
... , , , ... a leading provider of kidney care services for those diagnosed with ... announced that it will present three abstracts at the 3rd North ... on August 27-29 in Vancouver, British Columbia. , , ...
... ... , ... (Vocus) August 26, 2009 -- Bariatric Advantage , a Division of Catalina Lifesciences, ... the many bariatric surgical programs that are helping less fortunate patients "RECOVER" from obesity ...
... ... WAVE (Whole-Body Advanced Vibration Exercise) is pleased to announce that the ... Physiomed, a multi location health care provider network with comprehensive rehabilitation ... experience WAVE,s revolutionary technology in the Physiomed facilities, with the implementation ...
Cached Medicine News:Health News:Trans Ionics Announces New Service - Custom Separation Synthesis (CSS)(TM) 2Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania 2Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania 3Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania 4Health News:DaVita to Present Three Abstracts for the International Society for Peritoneal Dialysis 2Health News:Bariatric Advantage Launches Highly Anticipated RECOVER Program Through Obesity Action Coalition 2Health News:WAVE Begins Shipment of Vibration Technology to Physiomed Franchises 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: